G7 leaders' call on the fight against cancer
FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC
Jérôme Salomon and Lutz Dommel: Cancer Becomes a Global Strategic Priority in Historic G7 Declaration
Delta Goodrem Inspiring Cancer Journey: Hodgkin Lymphoma, Recovery, and Eurovision Return
LAGOON Trial: 3 Critical Results From Zepzelca in Second-Line SCLC
Neeraj Agarwal: AHA and ASCO Joint Statement on Defining Cardiovascular Endpoints in Oncology Trials
Yelena Janjigian Receives 2026 Fellowship Service Award at MSK
EMBER-3 PRO Analysis Supports Quality-of-Life Profile of Imlunestrant in Advanced ER-Positive/HER2-Negative Breast Cancer
On the occasion of International Childhood Cancer Day (ICCD) 2026, observed globally on 15 February to raise awareness and promote equitable access to quality cancer care for every child, a […]
The SITC Clinical Immuno-Oncology Network (SCION) Workshop is an intimate, intensive clinical trial development program organized by the Society for Immunotherapy of Cancer (SITC), designed to address the unique challenges in designing protocols specific to cancer immunotherapy. The 2026 SCION Workshop is scheduled for February 16-18, 2026, and will be held at The Westin Copley […]
The Multidisciplinary Radiopharmaceutical Therapy Symposium (MRPTS) will be held February 17–18, 2026, at JW Marriott Desert Springs, Palm Desert, California, with a live virtual option for remote attendees. This inaugural […]
ESMO Therapeutic Landscapes: Toxicity of Multispecific Antibodies and Immune-Cell Engagers 2026 is a specialized technical webinar scheduled for February 18, 2026, focused on the safety profiles and clinical management of […]
The ESMO Preceptorship on Metastatic Bladder and Kidney Cancer 2026: Lugano is a two-day educational course focusing on the management of metastatic bladder and kidney cancer, providing oncologists with a […]
The Advancing Cancer Research for Latinos and All Populations conference is a biennial international event scheduled for February 18-20, 2026, in San Antonio, Texas. Hosted by the Mays Cancer Center […]
The Targeted Therapies of Lung Cancer (TTLC) 2026 Meeting, organized by the International Association for the Study of Lung Cancer (IASLC), is a premier event for experts dedicated to advancing […]
The IASLC 2026 Targeted Therapies of Lung Cancer (TTLC) meeting is a premier international conference scheduled for February 18–21, 2026, in Huntington Beach, California. Organized by the International Association for […]
The AACR IO Conference 2026, titled Discovery and Innovation in Cancer Immunology: Revolutionizing Treatment through Immunotherapy, will take place from February 18–21, 2026, at JW Marriott Los Angeles L.A. Live. […]
The 2026 International Cancer Neuroscience Symposium, hosted by The University of Texas MD Anderson Cancer Center Cancer Neuroscience Program and Wiley's Advanced Portfolio, is a three-day dynamic hybrid event scheduled […]
The 2026 Multidisciplinary Head and Neck Cancers Symposium is a two-and-a-half-day event scheduled for February 19-21, 2026. Organized by ASTRO (American Society for Radiation Oncology) and co-sponsored by other key […]
The Advocates Webinar: Modernizing Oncology Endpoints, hosted virtually by Friends of Cancer Research (Friends), is a free, advocates-focused session scheduled for Thursday, February 19, 2026, from 12:00 PM to 1:00 […]
The Multinational Association of Supportive Care in Cancer (MASCC), in partnership with SIOG-NAHS and JASCC Geriatrics, will host a webinar titled "Closing the Gap in Geriatric Oncology: Recent Advances and […]
The APPOS Las Vegas 2026: Advanced Practice Providers Oncology Summit is a two-day continuing medical education conference organized by Horizon CME, scheduled for February 20th – 21st, 2026, at the […]
The Highlights in GI Oncology conference, hosted by Horizon CME, is a two-day educational program providing the latest science and practice-changing advances from the world's premier GI oncology event, the […]
The Oncology APP Leadership Forum 2026 is the 3rd annual two-day conference designed for current and aspiring Advanced Practice Provider (APP) leaders, managers, administrators, and directors in oncology. Scheduled for […]
